|
TROVE2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.226000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.320200E-03 |
| Normal-vs-Stage2 |
1.720820E-01 |
| Normal-vs-Stage3 |
6.368600E-01 |
| Normal-vs-Stage4 |
4.956400E-01 |
| Stage1-vs-Stage2 |
9.769200E-01 |
| Stage1-vs-Stage3 |
2.820500E-02 |
| Stage1-vs-Stage4 |
2.211600E-01 |
| Stage2-vs-Stage3 |
1.798980E-01 |
| Stage2-vs-Stage4 |
2.462600E-01 |
| Stage3-vs-Stage4 |
5.743000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.772300E-02 |
| Normal-vs-AfricanAmerican |
2.279800E-01 |
| Normal-vs-Asian |
2.104400E-01 |
| Caucasian-vs-AfricanAmerican |
8.367800E-01 |
| Caucasian-vs-Asian |
5.727000E-01 |
| AfricanAmerican-vs-Asian |
5.068400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.404600E-03 |
| Normal-vs-Female |
4.521600E-01 |
| Male-vs-Female |
3.302800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.001600E-01 |
| Normal-vs-Extreme_Weight |
4.676600E-03 |
| Normal-vs-Obese |
8.944200E-01 |
| Normal-vs-Extreme_Obese |
2.395400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.907800E-01 |
| Normal_Weight-vs-Obese |
6.028600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.688600E-01 |
| Extreme_Weight-vs-Obese |
3.764000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.563200E-01 |
| Obese-vs-Extreme_Obese |
3.975600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.783000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.091800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.502170E-03 |
| Normal-vs-Age(81-100Yrs) |
2.704500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.204200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.197710E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.905890E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.299300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.149900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.416400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.596400E-02 |
| Normal-VS-Type2 PRCC |
4.245500E-02 |
| Normal-VS-KIRP CIMP |
3.220800E-01 |
| Normal-VS-Unclassified PRCC |
7.802200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.063800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.735610E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.096400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.196200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.493000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.951830E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.150600E-04 |
| Normal-vs-N1 |
8.300000E-02 |
| Normal-vs-N2 |
4.343600E-01 |
| N0-vs-N1 |
5.042600E-03 |
| N0-vs-N2 |
1.144160E-01 |
| N1-vs-N2 |
6.076200E-01 |
|
|
